Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4153278, 8 pages
http://dx.doi.org/10.1155/2016/4153278
Clinical Study

Breaking the Taboo: Illicit Drug Use among Adolescents with Type 1 Diabetes Mellitus

1Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, 91-738 Lodz, Poland
2Department of Studies on Alcoholism and Other Dependencies, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland
3Students’ Scientific Circle at the Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, 91-738 Lodz, Poland
4Department of Pediatrics, Diabetology and Endocrinology, Medical University of Gdańsk, 80-211 Gdańsk, Poland

Received 15 July 2015; Revised 11 October 2015; Accepted 18 October 2015

Academic Editor: Andrea Scaramuzza

Copyright © 2016 Anna M. Hogendorf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-C. Suris and N. Parera, “Sex, drugs and chronic illness: health behaviours among chronically ill youth,” European Journal of Public Health, vol. 15, no. 5, pp. 484–488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. E. Scaramuzza, A. De Palma, C. Mameli, D. Spiri, L. Santoro, and G. V. Zuccotti, “Adolescents with type 1 diabetes and risky behaviour,” Acta Paediatrica, vol. 99, no. 8, pp. 1237–1241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Lee, J. R. Greenfield, K. Gilbert, and L. V. Campbell, “Recreational drug use in type 1 diabetes: an invisible accomplice to poor glycaemic control?” Internal Medicine Journal, vol. 42, no. 2, pp. 198–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. P. Laing, M. E. Jones, A. J. Swerdlow, A. C. Burden, and W. Gatling, “Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes,” Diabetes Care, vol. 28, no. 7, pp. 1618–1623, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. T. Webb, P. Lichtenstein, M. Dahlin, N. Kapur, J. F. Ludvigsson, and B. Runeson, “Unnatural deaths in a national cohort of people diagnosed with diabetes,” Diabetes Care, vol. 37, no. 8, pp. 2276–2283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Wibell, L. Nyström, J. Östman et al., “Increased mortality in diabetes during the first 10 years of the disease. A population-based study (DISS) in Swedish adults 15–34 years old at diagnosis,” Journal of Internal Medicine, vol. 249, no. 3, pp. 263–270, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Saunders, J. Democratis, J. Martin, and I. A. Macfarlane, “Intravenous drug abuse and Type 1 diabetes: financial and healthcare implications,” Diabetic Medicine, vol. 21, no. 12, pp. 1269–1273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. L. Isidro and S. Jorge, “Recreational drug abuse in patients hospitalized for diabetic ketosis or diabetic ketoacidosis,” Acta Diabetologica, vol. 50, no. 2, pp. 183–187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Lee, A. J. Nicoll, M. McDonough, and P. G. Colman, “Substance abuse in young patients with type I diabetes: easily neglected in complex medical management,” Internal Medicine Journal, vol. 35, no. 6, pp. 359–361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Glasgow, D. Tynan, R. Schwartz et al., “Alcohol and drug use in teenagers with diabetes mellitus,” Journal of Adolescent Health Care, vol. 12, no. 1, pp. 11–14, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Gold and J. Gladstein, “Substance use among adolescents with diabetes mellitus: preliminary findings,” Journal of Adolescent Health, vol. 14, no. 2, pp. 80–84, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Martínez-Aguayo, J. C. Araneda, D. Fernandez, A. Gleisner, V. Perez, and E. Codner, “Tobacco, alcohol, and illicit drug use in adolescents with diabetes mellitus,” Pediatric Diabetes, vol. 8, no. 5, pp. 265–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. S. H. Ng, D. A. Darko, and R. M. Hillson, “Street drug use among young patients with Type 1 diabetes in the UK,” Diabetic Medicine, vol. 21, no. 3, pp. 295–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Frey, B. Guthrie, C. Loveland-Cherry, P. S. Park, and C. M. Foster, “Risky behavior and risk in adolescents with IDDM,” Journal of Adolescent Health, vol. 20, no. 1, pp. 38–45, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. European School Survey Project on Alcohol and Other Drugs, http://www.espad.org/en/Reports–Documents/ESPAD-Documents/.
  16. C. Michael White, “How MDMA's pharmacology and pharmacokinetics drive desired effects and harms,” Journal of Clinical Pharmacology, vol. 54, no. 3, pp. 245–252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kovacs, D. Goldston, D. S. Obrosky, and L. K. Bonar, “Psychiatric disorders in youths with IDDM: rates and risk factors,” Diabetes Care, vol. 20, no. 1, pp. 36–44, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Butwicka, L. Frisén, C. Almqvist, B. Zethelius, and P. Lichtenstein, “Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study,” Diabetes Care, vol. 38, no. 3, pp. 453–459, 2015. View at Publisher · View at Google Scholar
  19. B. Johnson, C. Eiser, V. Young, S. Brierley, and S. Heller, “Prevalence of depression among young people with Type 1 diabetes: a systematic review,” Diabetic Medicine, vol. 30, no. 2, pp. 199–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Lee and L. V. Campbell, “Diabetic ketoacidosis: the usual villain or a scapegoat? A novel cause of severe metabolic acidosis in type 1 diabetes,” Diabetes Care, vol. 31, no. 3, article e13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. A. Warner, G. S. Greene, M. S. Buchsbaum, D. S. Cooper, and B. E. Robinson, “Diabetic ketoacidosis associated with cocaine use,” Archives of Internal Medicine, vol. 158, no. 16, pp. 1799–1802, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. E. A. Nyenwe, R. S. Loganathan, S. Blum et al., “Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital,” Endocrine Practice, vol. 13, no. 1, pp. 22–29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Abraham and R. Khardori, “Hyperglycemic hyperosmolar nonketotic syndrome as initial presentation of type 2 diabetes in a young cocaine abuser,” Diabetes Care, vol. 22, no. 8, pp. 1380–1381, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Gama, B. de Souza, A. Ossowski, and R. Perraro, “Diabetic ketoacidosis complicated by the use of ecstasy: a case report,” Journal of Medical Case Reports, vol. 4, no. 1, article 240, 2010. View at Publisher · View at Google Scholar
  25. P. Vanberg and D. Atar, “Androgenic anabolic steroid abuse and the cardiovascular system,” Handbook of Experimental Pharmacology, vol. 195, pp. 411–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Gonzalez and D. J. Nutt, “Gamma hydroxy butyrate abuse and dependency,” Journal of Psychopharmacology, vol. 19, no. 2, pp. 195–204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Razenberg, J. W. F. Elte, A. P. Rietveld, H. C. T. van Zaanen, and M. C. Cabezas, “A ‘smart’ type of Cushing's syndrome,” European Journal of Endocrinology, vol. 157, no. 6, pp. 779–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Permutt, D. W. Goodwin, R. Schwin, and S. Y. Hill, “The effect of marijuana on carbohydrate metabolism,” The American Journal of Psychiatry, vol. 133, no. 2, pp. 220–224, 1976. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Hall and L. Degenhardt, “Adverse health effects of non-medical cannabis use,” The Lancet, vol. 374, no. 9698, pp. 1383–1391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Radhakrishnan, S. T. Wilkinson, and D. C. D'Souza, “Gone to pot—a review of the association between cannabis and psychosis,” Frontiers in Psychiatry, vol. 5, article 54, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. European School Survey Project on Alcohol and Other Drugs, http://www.espad.org/en/Keyresult-Generator.